Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 12, 1998, Pages 1235-1240

  Hatlebakk, J G ^a   Katz, P O ^a   Kuo, B ^a   Castell, D O ^a  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; ESOPHAGUS PH; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; TIME FACTORS;

EID: 0031700062     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00426.x     Document Type: Article

References (27)

1. Hatlebakk JG, Berstad A. Endoscopic grading of reflux oesophagitis: What observations correlate with gastro-oesophageal reflux? Scand J Gastroenterol 1997; 32: 760-5.
2. Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of reflux in complicated oesophagitis. Gut 1987; 28; 1184-8.
3. Gonvers J-J, Zellweger J-P, Leuenbergher P, Fraser R. Asthma, respiratory disease and gastro-oesophageal reflux. Gullet 1993; 3(Suppl.): 53-9.
4. Bell NJV, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33; 118-24.
5. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and oesophageal 24-hour pH-monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990; 4: 485-95.
6. Peghini PL, Katz PO, Bracy N, Castell DO. Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors. Am J Gastroenterol 1998; 93: 763-7.
7. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994; 89: 989-91.
8. Castell DO, Castell JA (eds). Esophageal Motility Testing, 2nd edn. Norwalk: Appleton & Lange, 1994: 32-33.
9. Castell JA. Esophageal manometry. In: Castell DO, ed. The Esophagus, 2nd edn. Boston: Little, Brown and Company, 1995: 133-52.
10. Ter RB, Johnston BT, Castell DO. Exclusion of the meal period improves the clinical reliability of esophageal pH monitoring. J Clin Gastroenterol 1997; 25: 314-16.
11. Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64-9.
12. Hatlebakk JG, Katz PO, Castell DO. Proton pump inhibitors should be taken with meals for optimal control of gastric acidity. Gastroenterology 1998; 114: A144-5(Abstract).
13. Khoury R, Mohiuddin M, Katz P, Castell DO. Influence of body position on nighttime recumbent reflux in patients with GERD. Gastroenterology 1998; 114: A174(Abstract).
14. Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995; 9: 693-7.
15. Hatlebakk JG, Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet 1996; 31: 386-406.
16. Hirschowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991; 101: 1149-58.
17. Bell NJV, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastrooesophageal reflux disease. Digestion 1992; 51(Suppl. 1): 59-67.
18. Hatlebakk JG, Berstad A. Gastro-esophageal reflux during three months of therapy with ranitidine in reflux esophagitis. Scand J Gastroenterol 1996; 31: 954-8.
19. Moore JG, Englert E. Circadian rhythm of gastric acid secretion in man. Nature 1970; 226: 1264-5.
20. Moore JG, Wolfe M. The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1973; 9: 97-105.
21. Waldum HL, Amestad JS, Brenna E, Eide I, Syversen II, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649-53.
22. Sandvik AK, Brenna E, Waldum HL. Review article: The pharmacological inhibition of gastric acid secretion - tolerance and rebound. Aliment Pharmacol Ther 1997; 11: 1013-18.
23. Peghini P, Katz P, Gilbert J, Castell D. Ranitidine controls nocturnal gastric acid breakthrough during BID proton pump inhibitor treatment. Am J Gastroenterol 1997; 92: 1600.
24. Emde C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 1987; 28: 1177-88.
25. Armstrong D, Emde C, Blum AL. Twenty-four-hour intragastric pH-metry studies: easy to do but difficult to analyse. Eur J Gastroenterol Hepatol 1989; 1: 167-74.
26. Pursnani KG, Mohiuddin MA, Geisinger KR, Weinbaum G, Castell DO. Quantitative evaluation of the role of 'acid-burden' in production of feline esophagitis. Gastroenterology 1996; 110: A235(Abstract).
27. Lacey Smith J, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 683-9.